Literature DB >> 15968194

Aggressive behavior of stage I ovarian mucinous tumors lacking extensive infiltrative invasion: a report of four cases and review of the literature.

Catherine Ludwick1, C Blake Gilks, Dianne Miller, Hadi Yaziji, Philip B Clement.   

Abstract

Previous studies have indicated that mucinous carcinomas of the ovary associated with extraovarian spread at the time of presentation or follow-up almost always have extensive infiltrative invasion within the primary tumor. We present four cases of stage I ovarian mucinous tumors that lacked extensive infiltrative invasion but were associated with an unexpectedly aggressive behavior. The patients were 18, 20, 41, and 45 years of age at presentation. All four of them presented with an abdominal mass or increased abdominal girth. The tumors were all stage Ia, 17 to 37 centimeters in maximal dimension, and typically multicystic with solid areas. The number of blocks per centimeter of tumor diameter was 0.65, 0.88, 0.92, and 1.0 in the four tumors, respectively, a degree of sampling within that recommended in previous studies. Clinical findings supported that they were primary tumors rather than metastatic from an occult primary tumor. On microscopic examination, the tumors all contained foci of intraepithelial carcinoma and foci of invasion as follows: expansile invasion only (two cases), expansile invasion and microinvasive carcinoma (one case), and microinvasive carcinoma only (one case). The expansile invasion was extensive in each of the three cases in which it was present. On follow-up, each patient experienced recurrent disease 7 months to 4.5 years after diagnosis, including hematogenous spread to lung and/or bone and liver in three patients. Three of four patients developed intraperitoneal spread. Three of four patients died of disease, and one patient is alive with persistent disease. Although ovarian mucinous tumors with only expansile invasion or only microinvasive carcinoma are usually associated with an excellent prognosis, this study indicates that these tumors can rarely behave in an aggressive fashion with hematogenous spread and a fatal outcome. Some of these tumors may have contained unsampled foci of infiltrative invasion. Although the optimum level of sampling in mucinous tumors remains to be determined, we recommend additional sampling of tumors in which the initial sections reveal intraepithelial carcinoma, microinvasive carcinoma, expansile invasion, or combinations thereof.

Entities:  

Mesh:

Year:  2005        PMID: 15968194     DOI: 10.1097/01.pgp.0000159935.38913.57

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  6 in total

Review 1.  Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR).

Authors:  W Glenn McCluggage; Meagan J Judge; Blaise A Clarke; Ben Davidson; C Blake Gilks; Harry Hollema; Jonathan A Ledermann; Xavier Matias-Guiu; Yoshiki Mikami; Colin J R Stewart; Russell Vang; Lynn Hirschowitz
Journal:  Mod Pathol       Date:  2015-06-19       Impact factor: 7.842

2.  Prognostic similarity between ovarian mucinous carcinoma with expansile invasion and ovarian mucinous borderline tumor: A retrospective analysis.

Authors:  Taira Hada; Morikazu Miyamoto; Hiroki Ishibashi; Hiroko Matsuura; Takahiro Sakamoto; Soichiro Kakimoto; Hideki Iwahashi; Rie Suzuki; Kimiya Sato; Hitoshi Tsuda; Masashi Takano
Journal:  Medicine (Baltimore)       Date:  2021-08-13       Impact factor: 1.817

3.  Results of Fertility-Sparing Surgery for Expansile and Infiltrative Mucinous Ovarian Cancers.

Authors:  Sebastien Gouy; Marine Saidani; Amandine Maulard; Slim Bach-Hamba; Enrica Bentivegna; Alexandra Leary; Patricia Pautier; Mojgan Devouassoux-Shisheboran; Catherine Genestie; Philippe Morice
Journal:  Oncologist       Date:  2017-12-14

4.  REG4 Is Highly Expressed in Mucinous Ovarian Cancer: A Potential Novel Serum Biomarker.

Authors:  Laura Lehtinen; Pia Vesterkvist; Pia Roering; Taina Korpela; Liisa Hattara; Katja Kaipio; John-Patrick Mpindi; Johanna Hynninen; Annika Auranen; Ben Davidson; Caj Haglund; Kristiina Iljin; Seija Grenman; Harri Siitari; Olli Carpen
Journal:  PLoS One       Date:  2016-03-16       Impact factor: 3.240

5.  Survival and biomarker analysis for ovarian mucinous carcinoma according to invasive patterns: retrospective analysis and review literature.

Authors:  Taira Hada; Morikazu Miyamoto; Hiroki Ishibashi; Hiroko Matsuura; Takahiro Sakamoto; Soichiro Kakimoto; Hideki Iwahashi; Hitoshi Tsuda; Masashi Takano
Journal:  J Ovarian Res       Date:  2021-02-14       Impact factor: 4.234

6.  HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy.

Authors:  Jessica N McAlpine; Kimberly C Wiegand; Russell Vang; Bridgett M Ronnett; Anna Adamiak; Martin Köbel; Steve E Kalloger; Kenneth D Swenerton; David G Huntsman; C Blake Gilks; Dianne M Miller
Journal:  BMC Cancer       Date:  2009-12-10       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.